Health Check: Biotechs obey the Three Commandments of life sciences
Heramed falls victim to US healthcare funding cuts
D-Day looms for Mayne Pharma holders – or will there be a twist?
Biotechs are heeding the Three Commandments of Life Sciences, as evidenced by ASX announcements over the last few days.
Why have only three emerged from the Mount?
Inspired by Donald Trump's famed negotiating skills and the supermarkets' shrinkflation practices, we managed to whittle them down from ten – and got adultery removed for good measure.
Anatara cuts the pineapple in other ways
Commandment One: when a clinical trial faileth, do not throweth in the towel prematurely.
In the case of Anatara Lifesciences (ASX:ANR), the company dipped out with a phase II trial testing its drug candidate – Garp – on irritable bowel syndrome (IBS) patients.
Garp, as in Gastrointestinal ReProgramming, contains a form of bromelain, an enzyme found in pineapple stems of all things.
Enlisting 78 volunteers, the study failed to meet the primary endpoint of a meaningful improvement in IBS symptoms, compared to placebo.
This was despite a 40% 'sustained and consistent' improvement, as measured by the IBS symptom scoring system.
The gist is that while there was an 'apparent trend of pain and distension relief', the more subjective measures did not show a clear pattern of improvement and this affected the overall score.
For example, questions included "how dissatisfied are you with your bowel functioning the past 10 days?"
The answers 'appeared to confound the result, presumably because the underlying disease is still present with a level of symptomatology'.
Anatara is continuing its anti-obesity pre-clinical studies, which are expected to take about six months to complete.
The other lesson here is that in devising primary endpoints, one should be-eth bloody careful to picketh the right ones.
Chimeric seizes the day
Commandment Two: Don't wasteth a successful trial result: go-eth to the well.
True to that lore, Chimeric Therapeutics (ASX:CHM) on Friday requested a trading halt 'pending an announcement in relation to a capital raising'.
The shares are frozen until tomorrow, or possibly today if the news come through.
On Thursday Chimeric shares soared 60%, or two-thirds of the cents after the company said two out of three evaluable patients in its phase IIb trial had achieved a complete response.
A complete response means remission or – in layman's terms – a cure.
The third patient had 'achieved stable disease, whereby the cancer is neither increasing nor decreasing in extent or severity'.
The study tested Chimeric's natural killer (NK) cells, agents in the blood stream with heightened cancer busting powers.
Chimeric's candidate, CHM-0201 was administered alongside standard-of-care chemotherapy patients to the for acute myeloid leukemia.
The three patients are the first to be targeted of 20 subjects, with 12 enrolled as of December.
The first patient was dosed in June last year.
The three patients were ineligible for transplantation and had not been previously treated.
Honey – we shrunk the share base
Commandment Three: when one's share price plummeteth, one should seeketh to consolidate one's shares.
Imugene (ASX:IMU) proposes a share consolidation to reduce its circa 7.46 billion shares on issue by a factor of 34, subject to investor approval at an EGM.
Imugene shares have fallen more than 70% over the last two years – and lost close to 10% this morning.
In theory, the shares would be worth 68 cents a share post-consolidation.
Apart from the 'vibe' of a company no longer being in 'penny dreadful' territory, share consolidations don't change anything fundamentally.
Heramed loses US hospital partner
HeraMED (ASX:HMD) has fallen victim to Trumpian public healthcare funding cuts, with hospital partner Broward Health ceasing use of the company's digital foetal monitoring tool Heracare.
Heramed says Broward believed that Heracare worked quite well, including reducing pre-term births significantly.
But the First, Second and Third Commandment of US healthcare is that economic imperatives come before clinical ones.
As a Medicaid 'safety net' hospital, Broward took up Heracare courtesy of a state grant. As of April 1 this year, federal allotments to the states to fund such services have been reduced by US$8 billion annually.
Heramed has appointed a US healthcare commercialisation firm, Aspire Health Innovations, to further its US growth.
The company also is in commercial discussions with potential partners 'in other markets with stable healthcare policy environments.'
Vitura pots another one
Medical cannabis intermediary Vitura Health (ASX:VIT) has added another chain of clinics to its range of outlets, albeit indirectly.
Vitura's 50% joint venture Flora has acquired the digital platform Heyday Medical, 'one of Australia's most respected medicinal cannabis clinics'.
Established in 2020, the chain claims to have services more than more than 5000 patients.
The deal involves Flora paying $350,000 in cash, plus a 15% stake in Flora post-deal, the value of which has not been quantified.
Vitura owns the Canview marketplace, Doctors on Demand telehealth business, CDA Clinics (medical cannabis telehealth) and a the clinic chain Candor Medical.
Last November Flora acquired the Releaf Group, which operates telehealth and physical clinics.
Mayne and Island shares have a rest
Mayne Pharma (ASX:MYX) shares are in trading halt until Wednesday, pending news of a 'material announcement' pertaining to US dermatological group Cosette's $7.40 a share cash takeover offer.
Last Thursday, Mayne issued an independent report opining the offer was 'fair and reasonable', with an assessed value of $6.61 to $7.50 per share.
Barring any surprise, Mayne holders will meet on June 18 to approve the scheme of arrangement.
Meanwhile, Island Pharmaceuticals (ASX:ILA) shares are on trading halt pending a capital raising.
The developer of both a treatment and prophylactic for dengue fever, Island had cash of $4.8 million as of the end of March.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
an hour ago
- ABC News
Darling Downs Zoo reopens, as lion-attack victim recovers after losing arm
Darling Downs Zoo south of Toowoomba has reopened two days after a woman lost her arm in a lioness attack. The zoo's full program of visitor activities has resumed this morning, however Workplace Health and Safety Queensland continues to investigate the circumstances around Sunday's incident. The injured woman in her 50s underwent surgery yesterday morning and is recovering in a stable condition in Brisbane's Princess Alexandra Hospital. Queensland Health Minister Tim Nicholls confirmed she had lost her arm. Darling Downs Zoo operators said yesterday afternoon that the woman was a member of the owner's family and not a staff member. "She is well-versed in safety protocols around potentially dangerous animals," the zoo wrote in an online post. Darling Downs Zoo said the woman did not enter the enclosure. Workplace Health and Safety Queensland said a number of compliance notices had been issued to the zoo. Australian zookeeping standards require spatial buffers between big cats and any keepers that enter their enclosures. Conservation biologist Alex Braczkowski said this gold standard made attacks like Sunday's rare, but it was a reminder of the dangers of working with big cats. "If this had happened in western Uganda or eastern Kenya it's doubtful whether the victim would have been able to survive, just due to the proximity of medical care." Darling Downs Zoo said the lioness involved in the attack would not be put down.
ABC News
an hour ago
- ABC News
BHP ordered to pay workers an average $30,000 more after defeat in landmark labour hire ruling
Mining giant BHP has been defeated in a landmark test of the federal government's "same job, same pay" laws and ordered to pay 2,200 of its Central Queensland coal miners an average of $30,000 more. Labour hire workers at BHP's Saraji, Peak Downs and Goonyella Riverside mines will now receive the same wages as their directly employed peers. It is the largest ruling relating to the coal mining sector since the Albanese government's "same job, same pay" laws came into effect last year. The laws require labour hires to be offered the same pay and conditions as full-time employees when doing the same work. If applied to all labour hires across its mines, the ruling could cost BHP around $1.3 billion a year, according to the Australian Resources and Energy Employer Association (AREEA). The Mining and Energy Union made the application to the Fair Work Commission and BHP had argued for an exemption on the grounds that the workers were providing a service, not labour, but its case was unsuccessful. That service contractor exemption was added to the labour hire laws in negotiations with AREEA in 2023, and the association has renewed calls for further amendments following this case. The mining union's Queensland president, Mitch Hughes, said the ruling was a significant win for coal workers and marked a "nail in the coffin for BHP's sham labour hire model". "If you are doing the same job as the person beside you, you deserve the same pay," he said. "What we'd like to see is the likes of BHP and mining companies turn these jobs into permanent jobs." BHP has been contacted for comment but has previously warned such a ruling could put thousands of jobs at risk. The decision marks the seventeenth successful application for the union.
ABC News
an hour ago
- ABC News
Easy ways to obtain a medical certificate for sick or carer's leave
Winter has well and truly arrived — and so has cold and flu season — meaning some of us may need time off to care for ourselves or a loved one. Workplaces often require evidence for sick or carer's leave, so what are your options for getting that? According to the Fair Work Ombudsman, an employer can ask an employee to provide evidence showing they took leave because they were: Unable to work because of illness or injury, or Needed to provide care or support to an immediate family or household member because of illness, injury or an emergency This can be for as little as one day or part of a day off work, and an employee who does not supply documentation may not be entitled to be paid for their sick or carer's leave. However, Shae McCrystal, professor of Law at the University of Sydney Law School, on the traditional lands of the Gadigal people, says medical evidence is not always required for personal leave, and employees should familiarise themselves with their workplace's enterprise agreements and industrial awards. The Fair Work Ombudsman says: "While there are no strict rules on what type of evidence needs to be given, the evidence has to convince a reasonable person that the employee was genuinely entitled to the sick or carer's leave." Visiting a fully bulk-billing doctor for a free consultation is an efficient and cost-effective way to get a medical certificate. However, recent surveys by ABC News and the Royal Australian College of GPs show fewer than 10 per cent of GPs exclusively bulk-bill patients, with average out-of-pocket costs to see a GP ranging from about $40 to $55. Securing a GP appointment at short notice can also be difficult, especially for Australians living in regional and remote areas. Booking a telehealth appointment can be a convenient way of securing a medical certificate, particularly if you are physically unable to get to a doctor or cannot secure an appointment. These appointments are offered via video or phone, and patients who use a telehealth service are generally directed to a short questionnaire and then assessed by an Australian Health Practitioner Regulation Agency-approved health practitioner. Costs of telehealth consultations can vary, with some costing less than $20, but according to Queensland Health, a telehealth appointment "should cost the same as an in-person appointment". Pharmacists can also issue absence-from-work certificates for a range of minor ailments within the scope of their practice. The cost of a pharmacy-issued absence-from-work form usually ranges from $20 to $35 for a single-day certificate, and Pharmacy Guild of Australia's Victoria vice-president Anthony Tassone says they can be issued for illnesses such as cold and flu, diarrhoea or migraines and severe headaches, for example. "[Illness where] they're not well enough to work, but it should resolve soon," Mr Tassone says. The Fair Work Ombudsman says statutory declarations are also an acceptable form of evidence for sick or carer's leave. Although there is no cost involved in getting a statutory declaration (stat dec), it has historically involved downloading and printing the form, filling out facts that you declare to be true and accurate, and having the document signed by a witness such as a justice of the peace. However, under legislative changes that came in early 2024, it is now possible to make commonwealth stat decs using your Digital Identity by creating a myGovID and attaching it to your myGov account. Australian National University professor of law and regulation Veronica Taylor says digital and paper stat decs "have exactly the same effect".
